India’s Dr Reddy’s says open to boosting U.S. manufacturing as tariff threat looms
By Rishika Sadam and Kashish Tandon HYDERABAD (Reuters) -India’s Dr Reddy’s Laboratories, one of country’s largest generic drugmakers, said that it is open to expanding its manufacturing footprint in the key U.S. market as tariff threat looms. “We are more than open to work in the United States, to make in the United States when …
India’s Dr Reddy’s says open to boosting U.S. manufacturing as tariff threat looms Read More »





